Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a peripheral vasodilator. Its mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle, leading to vasodilation and improved blood flow.
## Primary Indications
* Treatment of peripheral vascular diseases such as arteriosclerosis obliterans, thromboangiitis obliterans (Buerger's disease), and Raynaud's disease.
* Management of intermittant claudication.
## Adult Dosing
* **Oral:** 10-20 mg three to four times daily.
* **Maximum:** Generally, 20 mg four times daily (80 mg/day).
## Pediatric Dosing
There is no established pediatric dosing for isoxsuprine hydrochloride.
## Dose Adjustments
No specific dose adjustments are routinely recommended for renal or hepatic impairment. However, caution should be exercised and lower doses may be considered in patients with severe impairment.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Should not be administered immediately postpartum or in patients with congenital heart defects due to risk of pulmonary embolism and cardiac arrhythmias.
## Adverse Effects
* **Common:** Nausea, vomiting, gastric distress, dizziness, weakness, flushing, nervousness.
* **Less Common:** Hypotension, tachycardia, rash, abdominal pain.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Other Vasodilators:** Additive hypotensive effects may occur.
## Monitoring
* Monitor blood pressure and heart rate for signs of hypotension or tachycardia.
* Assess for improvement in peripheral vascular symptoms (e.g., pain, claudication, skin temperature/color).
* Monitor for adverse effects.
## Clinical Pearls
* Isoxsuprine hydrochloride is generally not considered a first-line therapy for peripheral vascular disease due to limited evidence of efficacy and potential for adverse effects.
* Efficacy in improving blood flow and relieving symptoms can be variable.
* Avoid use in patients with hypotension or tachycardia.
* Discontinue use if symptoms do not improve after an adequate trial period.
***
*Disclaimer: This information is intended for healthcare professionals and does not replace a thorough review of the complete prescribing information and current clinical guidelines. Always verify the most up-to-date product information with the manufacturer's labeling and consult relevant clinical resources.*
